A new study proves the brain-selective estrogen prodrug DHED reverses memory and sleep issues caused by breast cancer therapies.
Morning Overview on MSN
Two cancer drugs — letrozole and irinotecan — reversed Alzheimer’s brain damage in mice and are heading to clinical trials
Researchers at UC San Francisco used a computational screen to identify two existing cancer drugs that, when given together, ...
Morning Overview on MSN
Researchers say letrozole and irinotecan, two approved cancer drugs, reversed Alzheimer’s brain damage in mice and could enter trials fast because they are alread…
A team led by researchers at the University of California, San Francisco has identified two existing cancer drugs that ...
(Juan Gaertner/Science Photo Library/Getty Images) Scientists looking to combat Alzheimer's disease may have found two ...
Giredestrant Plus Palbociclib Falls Short of Statistical Significance in Phase 3 Breast Cancer Trial
CDK4/6 inhibitor–based regimens represent the standard of care in the first-line treatment of women with ER-positive, ...
Most breast cancers are worsened by estrogens. To combat the recurrence of these cancers, clinicians treat patients with ...
Oral and poster presentations span three priority programs in breast, gynecologic, and gastrointestinal cancers, advancing ...
To her shock, her trans brother, Kenny Ethan Jones, offered his eggs. Eighteen challenging months later, Kizzy welcomed a ...
In 2024, one transgender man paused his hormone journey to donate his eggs to his sister after years of her infertility ...
AstraZeneca has presented new data from the SERENA-6 trial of camizestrant in advanced breast cancer that it hopes will ...
To Roche, a phase 3 flop in first-line breast cancer does not erase the megablockbuster potential of its oral SERD drug ...
Pfizer showcased multiple late-breakers at the American Society of Clinical Oncology’s annual conference but its biggest data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results